| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.729 | 0.004 | 0.729 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.554 0.004 DBMET01498 0.554 0.004 DBMET01500 | ||
| 0.658 | 0.003 | 0.658 | Check point kinase 1 inhibitor | 0.468 0.004 DBMET01498 0.472 0.004 DBMET01500 | ||
| 0.614 | 0.004 | 0.614 | EphB2 antagonist | 0.423 0.014 DBMET01498 0.438 0.012 DBMET01500 | ||
| 0.557 | 0.005 | 0.557 | Glycogen synthase kinase-3 inhibitor | 0.356 0.011 DBMET01498 0.413 0.008 DBMET01500 | ||
| 0.575 | 0.027 | 0.619 | MAP kinase 1 inhibitor | 0.619 0.016 DBMET01498 0.476 0.063 DBMET01500 | DBMET01498 | |
| 0.525 | 0.004 | 0.541 | Xanthine oxidase inhibitor | 0.541 0.003 DBMET01498 0.367 0.005 DBMET01500 | DBMET01498 | |
| 0.517 | 0.005 | 0.517 | Glycogen synthase kinase-3 beta inhibitor | 0.304 0.013 DBMET01498 0.365 0.009 DBMET01500 | ||
| 0.493 | 0.004 | 0.493 | Ribosomal protein S6 kinase inhibitor | 0.387 0.005 DBMET01498 0.449 0.004 DBMET01500 | ||
| 0.487 | 0.006 | 0.487 | RET inhibitor | 0.302 0.022 DBMET01498 0.263 0.029 DBMET01500 | ||
| 0.48 | 0.002 | 0.587 | Xanthine dehydrogenase inhibitor | 0.587 0.002 DBMET01498 0.352 0.003 DBMET01500 | DBMET01498 | |
| 0.47 | 0.004 | 0.47 | Protein kinase (CK2) alpha inhibitor | 0.467 0.004 DBMET01498 0.242 0.017 DBMET01500 | ||
| 0.469 | 0.005 | 0.469 | MAP kinase 9 inhibitor | 0.232 0.018 DBMET01498 0.32 0.01 DBMET01500 | ||
| 0.463 | 0.005 | 0.463 | Glycogen synthase kinase-3 alpha inhibitor | 0.374 0.008 DBMET01498 0.325 0.013 DBMET01500 | ||
| 0.464 | 0.029 | 0.47 | MAP kinase kinase 6 inhibitor | 0.356 0.088 DBMET01498 0.47 0.027 DBMET01500 | DBMET01500 | |
| 0.461 | 0.037 | 0.461 | Angiogenesis inhibitor | 0.306 0.09 DBMET01498 0.431 0.044 DBMET01500 | ||
| 0.419 | 0.003 | 0.419 | Protein kinase C delta inhibitor | 0.283 0.004 DBMET01498 0.28 0.004 DBMET01500 | ||
| 0.407 | 0.014 | 0.407 | CDC-like kinase 4 inhibitor | 0.19 0.073 DBMET01498 0.284 0.036 DBMET01500 | ||
| 0.402 | 0.019 | 0.402 | Clk dual-specificity kinase inhibitor | 0.211 0.073 DBMET01498 0.258 0.052 DBMET01500 | ||
| 0.376 | 0.004 | 0.376 | Uric acid excretion stimulant | 0.359 0.004 DBMET01498 0.271 0.005 DBMET01500 | ||
| 0.392 | 0.028 | 0.392 | Dyrk kinase inhibitor | 0.307 0.05 DBMET01498 0.234 0.079 DBMET01500 | ||
| 0.361 | 0.003 | 0.361 | Protein kinase B beta inhibitor | 0.242 0.004 DBMET01498 0.324 0.004 DBMET01500 | ||
| 0.391 | 0.041 | 0.391 | Nootropic | 0.215 0.139 DBMET01498 0.265 0.095 DBMET01500 | ||
| 0.36 | 0.013 | 0.36 | Vascular endothelial growth factor 3 antagonist | 0.231 0.032 DBMET01498 0.159 0.06 DBMET01500 | ||
| 0.36 | 0.016 | 0.36 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.214 0.066 DBMET01498 0.214 0.066 DBMET01500 | ||
| 0.344 | 0.005 | 0.369 | Protein kinase (CK2) inhibitor | 0.369 0.004 DBMET01498 0.175 0.024 DBMET01500 | DBMET01498 | |
| 0.342 | 0.003 | 0.342 | Protein kinase C theta inhibitor | 0.18 0.004 DBMET01498 0.221 0.004 DBMET01500 | ||
| 0.352 | 0.016 | 0.352 | TRKC antagonist | 0.196 0.069 DBMET01498 0.239 0.052 DBMET01500 | ||
| 0.344 | 0.022 | 0.344 | CDC-like kinase 2 inhibitor | 0.142 0.099 DBMET01498 0.157 0.089 DBMET01500 | ||
| 0.328 | 0.009 | 0.328 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.178 0.034 DBMET01498 0.248 0.018 DBMET01500 | ||
| 0.327 | 0.009 | 0.327 | Abl kinase inhibitor | 0.178 0.034 DBMET01498 0.247 0.018 DBMET01500 | ||
| 0.316 | 0.004 | 0.316 | Protein kinase B alpha inhibitor | 0.19 0.005 DBMET01498 0.239 0.004 DBMET01500 | ||
| 0.328 | 0.017 | 0.328 | Cyclin-dependent kinase inhibitor | 0.197 0.038 DBMET01498 0.209 0.035 DBMET01500 | ||
| 0.331 | 0.031 | 0.331 | Cyclic AMP phosphodiesterase inhibitor | 0.206 0.089 DBMET01498 0.159 0.137 DBMET01500 | ||
| 0.305 | 0.008 | 0.305 | Cyclin-dependent kinase 8 inhibitor | 0.198 0.037 DBMET01498 0.233 0.02 DBMET01500 | ||
| 0.322 | 0.031 | 0.322 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.174 0.076 DBMET01498 | ||
| 0.304 | 0.015 | 0.304 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.169 0.06 DBMET01498 0.245 0.027 DBMET01500 | ||
| 0.299 | 0.012 | 0.299 | Protein kinase (CK1) delta inhibitor | 0.166 0.044 DBMET01498 0.13 0.066 DBMET01500 | ||
| 0.302 | 0.017 | 0.302 | Protein kinase (CK1) inhibitor | 0.162 0.059 DBMET01498 0.121 0.091 DBMET01500 | ||
| 0.309 | 0.032 | 0.309 | MAP kinase kinase 2 inhibitor | 0.164 0.108 DBMET01498 0.165 0.108 DBMET01500 | ||
| 0.28 | 0.004 | 0.28 | Protein kinase C alpha inhibitor | 0.215 0.005 DBMET01498 0.211 0.005 DBMET01500 | ||
| 0.317 | 0.045 | 0.317 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.252 0.067 DBMET01498 | ||
| 0.281 | 0.013 | 0.281 | Cyclin-dependent kinase 1 inhibitor | 0.175 0.032 DBMET01498 0.189 0.028 DBMET01500 | ||
| 0.277 | 0.014 | 0.277 | MAP kinase kinase 3 inhibitor | 0.22 0.074 DBMET01498 0.223 0.068 DBMET01500 | ||
| 0.267 | 0.009 | 0.267 | MAP kinase 8 inhibitor | 0.145 0.031 DBMET01498 0.168 0.023 DBMET01500 | ||
| 0.275 | 0.022 | 0.275 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.103 0.078 DBMET01498 0.125 0.065 DBMET01500 | ||
| 0.295 | 0.045 | 0.295 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.154 0.108 DBMET01498 | ||
| 0.265 | 0.025 | 0.265 | Cytidine deaminase inhibitor | 0.147 0.078 DBMET01498 0.153 0.073 DBMET01500 | ||
| 0.26 | 0.02 | 0.589 | Phosphodiesterase inhibitor | 0.264 0.02 DBMET01498 0.589 0.004 DBMET01500 | DBMET01500 | |
| 0.315 | 0.078 | 0.315 | Calcium channel activator | 0.213 0.194 DBMET01500 | ||
| 0.243 | 0.006 | 0.243 | MAP kinase 10 inhibitor | 0.142 0.018 DBMET01498 0.127 0.021 DBMET01500 | ||
| 0.243 | 0.008 | 0.243 | Rho-associated kinase II inhibitor | 0.084 0.042 DBMET01498 0.097 0.033 DBMET01500 | ||
| 0.279 | 0.047 | 0.279 | Tyrosine kinase inhibitor | 0.126 0.104 DBMET01498 0.122 0.107 DBMET01500 | ||
| 0.259 | 0.027 | 0.259 | Protein kinase (CK1) gamma inhibitor | 0.119 0.091 DBMET01498 | ||
| 0.247 | 0.021 | 0.247 | Activin receptor-like kinase 2 inhibitor | 0.131 0.084 DBMET01498 0.133 0.082 DBMET01500 | ||
| 0.342 | 0.123 | 0.342 | 5 Hydroxytryptamine release inhibitor | |||
| 0.231 | 0.012 | 0.231 | Platelet activating factor alpha antagonist | 0.157 0.028 DBMET01498 0.129 0.039 DBMET01500 | ||
| 0.232 | 0.018 | 0.263 | Glutamate receptor antagonist | 0.263 0.014 DBMET01498 0.232 0.018 DBMET01500 | DBMET01498 | |
| 0.247 | 0.037 | 0.247 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.115 0.105 DBMET01498 | ||
| 0.219 | 0.01 | 0.219 | Rho-associated kinase inhibitor | 0.082 0.045 DBMET01498 0.107 0.031 DBMET01500 | ||
| 0.239 | 0.03 | 0.239 | Vascular endothelial growth factor antagonist | 0.146 0.056 DBMET01498 0.141 0.058 DBMET01500 | ||
| 0.217 | 0.009 | 0.217 | MAP kinase kinase 4 inhibitor | 0.185 0.021 DBMET01498 0.172 0.031 DBMET01500 | ||
| 0.22 | 0.013 | 0.22 | Check point kinase 2 inhibitor | 0.148 0.032 DBMET01498 0.142 0.034 DBMET01500 | ||
| 0.222 | 0.017 | 0.222 | MAP kinase 12 inhibitor | 0.175 0.031 DBMET01498 0.15 0.042 DBMET01500 | ||
| 0.259 | 0.054 | 0.263 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.263 0.051 DBMET01498 0.196 0.177 DBMET01500 | DBMET01498 | |
| 0.206 | 0.006 | 0.206 | Death-associated protein kinase 1 inhibitor | 0.178 0.014 DBMET01498 0.164 0.023 DBMET01500 | ||
| 0.251 | 0.052 | 0.251 | Death-associated protein kinase 3 inhibitor | 0.144 0.132 DBMET01498 | ||
| 0.212 | 0.018 | 0.212 | MAP kinase 13 inhibitor | 0.158 0.032 DBMET01498 0.121 0.055 DBMET01500 | ||
| 0.223 | 0.03 | 0.223 | Vascular endothelial growth factor 2 antagonist | 0.134 0.055 DBMET01498 0.122 0.06 DBMET01500 | ||
| 0.198 | 0.008 | 0.198 | Protein kinase B gamma inhibitor | 0.107 0.029 DBMET01498 0.098 0.033 DBMET01500 | ||
| 0.217 | 0.027 | 0.321 | Hemostatic | 0.321 0.014 DBMET01498 0.183 0.041 DBMET01500 | DBMET01498 | |
| 0.204 | 0.017 | 0.204 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.098 0.055 DBMET01498 0.107 0.048 DBMET01500 | ||
| 0.187 | 0.005 | 0.187 | Phosphodiesterase X inhibitor | 0.145 0.006 DBMET01498 0.075 0.015 DBMET01500 | ||
| 0.187 | 0.005 | 0.187 | Phosphodiesterase 10A inhibitor | 0.145 0.006 DBMET01498 0.075 0.015 DBMET01500 | ||
| 0.209 | 0.029 | 0.209 | Cyclin-dependent kinase 3 inhibitor | 0.164 0.069 DBMET01498 0.157 0.081 DBMET01500 | ||
| 0.203 | 0.025 | 0.203 | Aurora-A kinase inhibitor | 0.087 0.077 DBMET01498 0.128 0.05 DBMET01500 | ||
| 0.183 | 0.006 | 0.183 | CDC7 inhibitor | 0.161 0.008 DBMET01498 0.083 0.033 DBMET01500 | ||
| 0.199 | 0.022 | 0.203 | Granulocyte macrophage colony stimulating factor antagonist | 0.105 0.066 DBMET01498 0.203 0.021 DBMET01500 | DBMET01500 | |
| 0.187 | 0.011 | 0.187 | Glutamate (mGluR) antagonist | 0.131 0.022 DBMET01498 0.14 0.019 DBMET01500 | ||
| 0.224 | 0.052 | 0.224 | LIM domain kinase 1 inhibitor | |||
| 0.237 | 0.068 | 0.237 | MAP-kinase-activated kinase 5 inhibitor | 0.231 0.073 DBMET01498 | ||
| 0.335 | 0.168 | 0.335 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.227 | 0.06 | 0.227 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.158 0.118 DBMET01498 | ||
| 0.201 | 0.034 | 0.201 | Death-associated protein kinase 2 inhibitor | 0.201 0.034 DBMET01498 0.167 0.072 DBMET01500 | ||
| 0.19 | 0.025 | 0.19 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.175 0.037 DBMET01498 0.152 0.069 DBMET01500 | ||
| 0.198 | 0.036 | 0.198 | c-Src kinase inhibitor | 0.097 0.092 DBMET01498 0.151 0.055 DBMET01500 | ||
| 0.195 | 0.033 | 0.195 | Mannose-6-phosphate isomerase inhibitor | 0.173 0.047 DBMET01498 0.14 0.074 DBMET01500 | ||
| 0.205 | 0.044 | 0.205 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.164 | 0.005 | 0.164 | MAP kinase kinase 9 inhibitor | 0.072 0.019 DBMET01498 0.062 0.029 DBMET01500 | ||
| 0.181 | 0.023 | 0.181 | Beta amyloid protein antagonist | 0.135 0.052 DBMET01498 | ||
| 0.177 | 0.019 | 0.177 | Pim-1 kinase inhibitor | 0.091 0.067 DBMET01498 | ||
| 0.17 | 0.013 | 0.17 | Pim-3 kinase inhibitor | 0.127 0.027 DBMET01498 0.088 0.062 DBMET01500 | ||
| 0.215 | 0.06 | 0.215 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.166 | 0.016 | 0.166 | Raf kinase inhibitor | 0.077 0.048 DBMET01498 0.085 0.041 DBMET01500 | ||
| 0.202 | 0.053 | 0.202 | Src kinase inhibitor | 0.119 0.108 DBMET01498 0.134 0.096 DBMET01500 | ||
| 0.161 | 0.012 | 0.161 | MAP-kinase-activated kinase inhibitor | 0.118 0.027 DBMET01498 0.1 0.039 DBMET01500 | ||
| 0.187 | 0.038 | 0.187 | Alkaline phosphatase inhibitor | 0.162 0.052 DBMET01498 | ||
| 0.182 | 0.033 | 0.194 | MAP kinase 3 inhibitor | 0.194 0.027 DBMET01498 | DBMET01498 | |
| 0.173 | 0.026 | 0.198 | MAP kinase kinase kinase inhibitor | 0.096 0.071 DBMET01498 0.198 0.019 DBMET01500 | DBMET01500 | |
| 0.175 | 0.03 | 0.175 | Cyclin-dependent kinase 2 inhibitor | 0.114 0.057 DBMET01498 0.131 0.046 DBMET01500 | ||
| 0.159 | 0.017 | 0.159 | Leucine-rich repeat kinase 2 inhibitor | 0.099 0.043 DBMET01498 | ||
| 0.169 | 0.028 | 0.169 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.087 0.065 DBMET01500 | ||
| 0.155 | 0.018 | 0.212 | MAP kinase 14 inhibitor | 0.212 0.01 DBMET01500 | DBMET01500 | |
| 0.2 | 0.063 | 0.2 | Growth factor agonist | 0.184 0.081 DBMET01498 0.168 0.106 DBMET01500 | ||
| 0.155 | 0.019 | 0.155 | ALK inhibitor | 0.098 0.042 DBMET01498 0.078 0.063 DBMET01500 | ||
| 0.174 | 0.039 | 0.174 | MAP kinase kinase inhibitor | 0.119 0.074 DBMET01498 0.116 0.078 DBMET01500 | ||
| 0.149 | 0.014 | 0.149 | Tyk2 inhibitor | 0.089 0.032 DBMET01498 | ||
| 0.174 | 0.04 | 0.174 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.136 | 0.003 | 0.136 | Bombesin agonist | 0.116 0.004 DBMET01498 0.115 0.004 DBMET01500 | ||
| 0.165 | 0.033 | 0.165 | Cyclin-dependent kinase 5 inhibitor | 0.113 0.064 DBMET01498 0.142 0.045 DBMET01500 | ||
| 0.143 | 0.012 | 0.143 | MAP-kinase-activated kinase 2 inhibitor | 0.098 0.029 DBMET01498 0.085 0.039 DBMET01500 | ||
| 0.186 | 0.056 | 0.186 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.179 | 0.049 | 0.179 | Tyrosine-protein kinase receptor antagonist | 0.109 0.097 DBMET01498 | ||
| 0.166 | 0.04 | 0.166 | Aurora-B kinase inhibitor | 0.097 0.086 DBMET01498 0.129 0.058 DBMET01500 | ||
| 0.14 | 0.017 | 0.14 | Fibroblast growth factor 3 antagonist | 0.08 0.051 DBMET01498 0.073 0.06 DBMET01500 | ||
| 0.163 | 0.043 | 0.163 | TRKA antagonist | 0.11 0.077 DBMET01498 | ||
| 0.131 | 0.013 | 0.131 | MAP kinase kinase 10 inhibitor | 0.063 0.053 DBMET01498 0.067 0.045 DBMET01500 | ||
| 0.146 | 0.03 | 0.146 | Activin receptor-like kinase 4 inhibitor | 0.096 0.095 DBMET01498 | ||
| 0.198 | 0.082 | 0.198 | Pyruvate kinase inhibitor | 0.16 0.107 DBMET01498 0.194 0.084 DBMET01500 | ||
| 0.237 | 0.121 | 0.237 | Ca(v)3.3 blocker | |||
| 0.204 | 0.088 | 0.204 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.123 | 0.008 | 0.185 | AMPA receptor antagonist | 0.132 0.007 DBMET01498 0.185 0.005 DBMET01500 | DBMET01500 | |
| 0.162 | 0.048 | 0.162 | Toll-Like receptor antagonist | 0.115 0.092 DBMET01500 | ||
| 0.115 | 0.003 | 0.115 | Bombesin 3 receptor agonist | 0.097 0.004 DBMET01498 0.096 0.004 DBMET01500 | ||
| 0.138 | 0.027 | 0.138 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.098 0.047 DBMET01498 0.094 0.052 DBMET01500 | ||
| 0.125 | 0.018 | 0.125 | Raf kinase B inhibitor | 0.057 0.043 DBMET01500 | ||
| 0.123 | 0.018 | 0.123 | Glutamate (mGluR) agonist | 0.064 0.041 DBMET01498 | ||
| 0.126 | 0.024 | 0.126 | MAP kinase 11 inhibitor | 0.072 0.053 DBMET01498 0.108 0.031 DBMET01500 | ||
| 0.112 | 0.01 | 0.112 | mTOR inhibitor | 0.076 0.019 DBMET01498 0.051 0.037 DBMET01500 | ||
| 0.116 | 0.016 | 0.116 | I kappa B kinase 1 inhibitor | 0.064 0.057 DBMET01500 | ||
| 0.116 | 0.017 | 0.116 | Phosphatidylinositol kinase inhibitor | 0.073 0.031 DBMET01498 0.054 0.048 DBMET01500 | ||
| 0.11 | 0.015 | 0.11 | Toll-Like receptor 7 antagonist | |||
| 0.109 | 0.015 | 0.109 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.067 0.026 DBMET01498 0.049 0.038 DBMET01500 | ||
| 0.134 | 0.039 | 0.187 | Cyclin-dependent kinase 9 inhibitor | 0.187 0.025 DBMET01500 | DBMET01500 | |
| 0.116 | 0.023 | 0.116 | Adenosine A2 receptor antagonist | 0.076 0.037 DBMET01498 0.087 0.031 DBMET01500 | ||
| 0.141 | 0.05 | 0.32 | Platelet activating factor antagonist | 0.32 0.009 DBMET01500 | DBMET01500 | |
| 0.163 | 0.072 | 0.163 | Polo-like kinase-3 inhibitor | |||
| 0.098 | 0.007 | 0.098 | DNA-dependent protein kinase inhibitor | 0.053 0.019 DBMET01498 0.073 0.01 DBMET01500 | ||
| 0.114 | 0.024 | 0.114 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.11 0.025 DBMET01500 | ||
| 0.106 | 0.017 | 0.106 | Protein kinase C iota inhibitor | 0.057 0.044 DBMET01498 0.075 0.029 DBMET01500 | ||
| 0.109 | 0.021 | 0.109 | Fibroblast growth factor 2 antagonist | 0.073 0.039 DBMET01498 | ||
| 0.118 | 0.031 | 0.118 | mTOR complex 1 inhibitor | 0.095 0.073 DBMET01498 | ||
| 0.107 | 0.02 | 0.107 | Janus tyrosine kinase 1 inhibitor | 0.049 0.047 DBMET01498 | ||
| 0.091 | 0.004 | 0.091 | Vascular adhesion protein 1 inhibitor | 0.038 0.028 DBMET01498 0.037 0.03 DBMET01500 | ||
| 0.154 | 0.067 | 0.154 | Growth factor antagonist | |||
| 0.122 | 0.036 | 0.15 | DNA directed RNA polymerase inhibitor | 0.103 0.053 DBMET01498 0.15 0.024 DBMET01500 | DBMET01500 | |
| 0.121 | 0.035 | 0.121 | Hepatocyte growth factor antagonist | 0.085 0.068 DBMET01498 | ||
| 0.089 | 0.004 | 0.089 | Alpha 1d adrenoreceptor agonist | 0.037 0.029 DBMET01498 0.042 0.023 DBMET01500 | ||
| 0.097 | 0.013 | 0.097 | Protein kinase C epsilon inhibitor | |||
| 0.157 | 0.074 | 0.157 | Peroxidase inhibitor | 0.117 0.103 DBMET01498 | ||
| 0.095 | 0.012 | 0.095 | Exportin-1 inhibitor | |||
| 0.095 | 0.012 | 0.095 | Cyclin-dependent kinase 6 inhibitor | 0.094 0.012 DBMET01498 0.075 0.026 DBMET01500 | ||
| 0.108 | 0.027 | 0.204 | Phosphodiesterase 3A inhibitor | 0.204 0.008 DBMET01498 0.081 0.054 DBMET01500 | DBMET01498 | |
| 0.175 | 0.094 | 0.175 | I kappa B kinase epsilon inhibitor | |||
| 0.136 | 0.057 | 0.136 | TRKB antagonist | |||
| 0.096 | 0.019 | 0.096 | DNA gyrase inhibitor | 0.075 0.031 DBMET01498 0.08 0.026 DBMET01500 | ||
| 0.089 | 0.013 | 0.089 | Toll-Like receptor 8 antagonist | |||
| 0.111 | 0.035 | 0.112 | Polo-like kinase-1 inhibitor | 0.112 0.035 DBMET01500 | DBMET01500 | |
| 0.099 | 0.023 | 0.099 | Adenosine A1 receptor antagonist | 0.06 0.039 DBMET01498 0.071 0.032 DBMET01500 | ||
| 0.108 | 0.033 | 0.108 | Janus tyrosine kinase 2 inhibitor | |||
| 0.11 | 0.037 | 0.11 | Stem cell growth factor agonist | 0.085 0.059 DBMET01500 | ||
| 0.103 | 0.03 | 0.103 | Rho-associated kinase I inhibitor | 0.07 0.056 DBMET01500 | ||
| 0.198 | 0.126 | 0.198 | DNA synthesis inhibitor | 0.182 0.15 DBMET01500 | ||
| 0.139 | 0.068 | 0.139 | Cyclin-dependent kinase 7 inhibitor | 0.121 0.084 DBMET01500 | ||
| 0.102 | 0.032 | 0.104 | p38 MAP kinase inhibitor | 0.104 0.031 DBMET01500 | DBMET01500 | |
| 0.095 | 0.025 | 0.095 | MAP kinase kinase 8 inhibitor | 0.062 0.059 DBMET01498 | ||
| 0.135 | 0.065 | 0.275 | M17 leucyl aminopeptidase inhibitor | 0.275 0.016 DBMET01498 | DBMET01498 | |
| 0.105 | 0.037 | 0.105 | Bcr-Abl kinase inhibitor | 0.098 0.043 DBMET01500 | ||
| 0.072 | 0.006 | 0.072 | DNA gyrase subunit B inhibitor | 0.046 0.016 DBMET01498 | ||
| 0.083 | 0.017 | 0.102 | Fatty acid synthase inhibitor | 0.102 0.01 DBMET01498 0.095 0.012 DBMET01500 | DBMET01498 | |
| 0.133 | 0.07 | 0.133 | Sodium channel (voltage-gated) blocker | |||
| 0.109 | 0.046 | 0.109 | CDK/cyclin complex inhibitor | |||
| 0.1 | 0.038 | 0.1 | I kappa B kinase inhibitor | |||
| 0.084 | 0.024 | 0.084 | Protein kinase C beta inhibitor | 0.067 0.054 DBMET01498 | ||
| 0.134 | 0.074 | 0.134 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.086 | 0.027 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.087 | 0.029 | 0.087 | Cyclin E inhibitor | |||
| 0.068 | 0.01 | 0.068 | Glutamate (mGluR group II) agonist | 0.036 0.023 DBMET01498 | ||
| 0.073 | 0.017 | 0.075 | Adenosine A2b receptor antagonist | 0.062 0.023 DBMET01498 0.075 0.016 DBMET01500 | DBMET01500 | |
| 0.065 | 0.01 | 0.065 | Glutamate (mGluR2) agonist | 0.031 0.023 DBMET01498 | ||
| 0.105 | 0.053 | 0.105 | Protein kinase C mu inhibitor | 0.096 0.06 DBMET01498 | ||
| 0.081 | 0.031 | 0.081 | Adenosine A2a receptor antagonist | |||
| 0.133 | 0.084 | 0.133 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.085 | 0.037 | 0.085 | Adenosine A3 receptor antagonist | 0.075 0.05 DBMET01498 | ||
| 0.051 | 0.007 | 0.051 | ATR kinase inhibitor | 0.033 0.022 DBMET01498 0.03 0.029 DBMET01500 | ||
| 0.081 | 0.037 | 0.081 | Glutamate (mGluR group I) antagonist | 0.063 0.059 DBMET01498 0.067 0.053 DBMET01500 | ||
| 0.071 | 0.027 | 0.071 | Heat shock protein 90 beta antagonist | 0.063 0.035 DBMET01498 | ||
| 0.125 | 0.081 | 0.142 | Toll-Like receptor 9 antagonist | 0.142 0.068 DBMET01500 | DBMET01500 | |
| 0.05 | 0.007 | 0.05 | Carnitine palmitoyltransferase 1A inhibitor | 0.034 0.013 DBMET01498 0.031 0.016 DBMET01500 | ||
| 0.084 | 0.042 | 0.084 | Janus tyrosine kinase 3 inhibitor | |||
| 0.099 | 0.058 | 0.099 | Fibroblast growth factor 1 antagonist | |||
| 0.061 | 0.021 | 0.061 | Glutamate (mGluR5) antagonist | 0.043 0.037 DBMET01498 | ||
| 0.066 | 0.027 | 0.066 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.159 | 0.121 | 0.159 | HERG channel blocker | |||
| 0.12 | 0.082 | 0.12 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.086 | 0.048 | 0.086 | Glutamate receptor agonist | |||
| 0.062 | 0.025 | 0.062 | Transforming growth factor beta 1 antagonist | |||
| 0.13 | 0.094 | 0.13 | MAP3K9 inhibitor | |||
| 0.085 | 0.05 | 0.085 | Transforming growth factor beta 3 antagonist | |||
| 0.12 | 0.085 | 0.12 | Lck kinase inhibitor | |||
| 0.076 | 0.044 | 0.113 | Benzodiazepine agonist | 0.113 0.019 DBMET01500 | DBMET01500 | |
| 0.075 | 0.043 | 0.075 | Orexin receptor 1 antagonist | |||
| 0.135 | 0.106 | 0.135 | CF transmembrane conductance regulator agonist | |||
| 0.073 | 0.044 | 0.073 | Transforming growth factor antagonist | |||
| 0.046 | 0.018 | 0.046 | Glutamate (mGluR group II) antagonist | |||
| 0.063 | 0.035 | 0.063 | Phosphatidylinositol 3-kinase delta inhibitor | 0.053 0.044 DBMET01498 | ||
| 0.057 | 0.03 | 0.057 | Factor IXa inhibitor | 0.057 0.029 DBMET01500 | ||
| 0.077 | 0.051 | 0.077 | CYP2A6 inhibitor | |||
| 0.073 | 0.047 | 0.073 | Phosphodiesterase VIII inhibitor | 0.073 0.047 DBMET01500 | ||
| 0.092 | 0.066 | 0.092 | CDK2/cyclin A inhibitor | 0.081 0.079 DBMET01500 | ||
| 0.057 | 0.034 | 0.057 | Pim-2 kinase inhibitor | |||
| 0.068 | 0.046 | 0.068 | Nav1.7 sodium channel blocker | |||
| 0.081 | 0.059 | 0.081 | Protein kinase A inhibitor | |||
| 0.038 | 0.017 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.107 | 0.086 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.153 | 0.134 | 0.153 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.041 | 0.023 | 0.043 | CF transmembrane conductance regulator antagonist | 0.039 0.03 DBMET01498 0.043 0.017 DBMET01500 | DBMET01500 | |
| 0.037 | 0.019 | 0.037 | Carnitine palmitoyltransferase inhibitor | |||
| 0.062 | 0.044 | 0.073 | Phosphodiesterase 1C inhibitor | 0.073 0.026 DBMET01498 | DBMET01498 | |
| 0.033 | 0.016 | 0.033 | Glutamate (mGluR2) antagonist | |||
| 0.051 | 0.034 | 0.051 | Alpha 1b adrenoreceptor agonist | |||
| 0.08 | 0.064 | 0.08 | GABA A receptor agonist | |||
| 0.088 | 0.075 | 0.136 | Vascular endothelial growth factor 1 antagonist | 0.136 0.046 DBMET01498 | DBMET01498 | |
| 0.017 | 0.005 | 0.028 | Egl nine homolog 2 inhibitor | 0.028 0.004 DBMET01498 | DBMET01498 | |
| 0.059 | 0.048 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.052 | 0.041 | 0.052 | Myc inhibitor | |||
| 0.019 | 0.009 | 0.027 | CC chemokine 9 receptor antagonist | 0.027 0.004 DBMET01500 | DBMET01500 | |
| 0.073 | 0.064 | 0.073 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.027 | 0.019 | 0.042 | Protocollagen prolyl hydroxylase inhibitor | 0.042 0.007 DBMET01498 | DBMET01498 | |
| 0.06 | 0.052 | 0.06 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.036 | 0.029 | 0.036 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.042 | 0.035 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.096 | 0.09 | 0.096 | CDC-like kinase 3 inhibitor | |||
| 0.051 | 0.045 | 0.051 | Bombesin 3 receptor antagonist | |||
| 0.008 | 0.003 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.072 | 0.067 | 0.072 | Platelet growth factor antagonist | |||
| 0.062 | 0.058 | 0.062 | Syk tyrosine kinase inhibitor | |||
| 0.054 | 0.05 | 0.058 | Cyclin A inhibitor | 0.058 0.045 DBMET01500 | DBMET01500 | |
| 0.028 | 0.024 | 0.033 | MAP3K8 inhibitor | 0.033 0.012 DBMET01500 | DBMET01500 | |
| 0.033 | 0.029 | 0.033 | Orexin receptor 2 antagonist | |||
| 0.042 | 0.038 | 0.042 | Glutamate (mGluR5) agonist | |||
| 0.053 | 0.05 | 0.053 | CDK2/cyclin E inhibitor | |||
| 0.06 | 0.057 | 0.06 | Orexin receptor antagonist | |||
| 0.035 | 0.034 | 0.035 | MAP3K5 inhibitor | |||
| 0.204 | 0.203 | 0.204 | GABA C receptor rho-3 antagonist | |||
| 0.053 | 0.055 | 0.059 | Cyclin A2 inhibitor | 0.059 0.048 DBMET01500 | DBMET01500 | |
| 0.053 | 0.059 | 0.113 | Phosphodiesterase III inhibitor | 0.113 0.018 DBMET01498 | DBMET01498 | |
| 0.029 | 0.036 | 0.055 | Factor XI inhibitor | 0.055 0.008 DBMET01498 0.039 0.016 DBMET01500 | DBMET01498 | |
| 0.042 | 0.05 | 0.045 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 DBMET01500 | DBMET01500 | |
| 0.043 | 0.052 | 0.047 | Potassium channel (Inward rectifier) activator | 0.047 0.043 DBMET01500 | DBMET01500 | |
| 0.019 | 0.032 | 0.026 | CXC chemokine 2 receptor antagonist | 0.026 0.019 DBMET01498 | DBMET01498 | |
| 0.072 | 0.085 | 0.08 | Factor XII inhibitor | 0.08 0.066 DBMET01500 | DBMET01500 | |
| 0.037 | 0.064 | 0.055 | Benzodiazepine inverse agonist | 0.055 0.019 DBMET01500 | DBMET01500 | |
| 0.052 | 0.085 | 0.086 | CXC chemokine receptor antagonist | 0.086 0.033 DBMET01500 | DBMET01500 | |
| 0.006 | 0.049 | 0.013 | Egl nine homolog 1 inhibitor | 0.013 0.012 DBMET01498 | DBMET01498 | |
| 0.024 | 0.072 | 0.057 | Factor XIa inhibitor | 0.057 0.014 DBMET01498 | DBMET01498 | |
| 0.025 | 0.074 | 0.101 | Phosphodiesterase 3B inhibitor | 0.101 0.011 DBMET01498 | DBMET01498 | |
| 0.061 | 0.12 | 0.092 | Potassium channel activator | 0.092 0.058 DBMET01500 | DBMET01500 | |
| 0.03 | 0.093 | 0.202 | Phosphodiesterase 4C inhibitor | 0.202 0.005 DBMET01500 | DBMET01500 | |
| 0.057 | 0.125 | 0.236 | Bronchodilator | 0.236 0.014 DBMET01500 | DBMET01500 | |
| 0.099 | 0.174 | 0.124 | Heat shock protein 90 alpha antagonist | 0.124 0.12 DBMET01500 | DBMET01500 | |
| 0.035 | 0.123 | 0.079 | Phosphodiesterase 4B inhibitor | 0.079 0.037 DBMET01500 | DBMET01500 | |
| 0.019 | 0.127 | 0.384 | Phosphodiesterase 4A inhibitor | 0.384 0.004 DBMET01500 | DBMET01500 | |
| 0.035 | 0.15 | 0.124 | Phosphodiesterase IV inhibitor | 0.124 0.031 DBMET01500 | DBMET01500 | |
| 0.138 | 0.256 | 0.181 | Nitric-oxide synthase stimulant | 0.181 0.125 DBMET01500 | DBMET01500 | |
| 0.096 | 0.226 | 0.28 | Platelet aggregation inhibitor | 0.28 0.041 DBMET01500 | DBMET01500 | |
| 0.024 | 0.155 | 0.074 | Farnesyltransferase inhibitor | 0.074 0.014 DBMET01500 | DBMET01500 | |
| 0.178 | 0.309 | 0.236 | Cyclophilin D inhibitor | 0.236 0.229 DBMET01498 | DBMET01498 | |
| 0.024 | 0.19 | 0.237 | Phosphodiesterase 4D inhibitor | 0.237 0.008 DBMET01500 | DBMET01500 | |
| 0.022 | 0.19 | 0.064 | HIV-1 reverse transcriptase inhibitor | 0.064 0.055 DBMET01498 | DBMET01498 | |
| 0.036 | 0.206 | 0.114 | Chemokine receptor antagonist | 0.114 0.052 DBMET01500 | DBMET01500 | |
| 0.119 | 0.304 | 0.209 | Vasodilator, peripheral | 0.209 0.166 DBMET01500 | DBMET01500 | |
| 0.1 | 0.389 | 0.637 | Toll-Like receptor 7 agonist | 0.637 0.013 DBMET01500 | DBMET01500 | |
| 0.063 | 0.354 | 0.328 | Tumour necrosis factor alpha release inhibitor | 0.328 0.044 DBMET01500 | DBMET01500 | |
| 0.093 | 0.408 | 0.627 | Toll-Like receptor agonist | 0.627 0.014 DBMET01500 | DBMET01500 | |
| 0.049 | 0.409 | 0.29 | Vasodilator | 0.29 0.052 DBMET01500 | DBMET01500 | |
| 0.005 | 0.384 | 0.065 | Dopamine D4 agonist | 0.065 0.025 DBMET01500 | DBMET01500 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |